Literature DB >> 19576334

Prevalence and clinical characteristics of right ventricular dysfunction in transient stress cardiomyopathy.

Timothy P Fitzgibbons1, Christopher Madias, Adhar Seth, Joseph L Bouchard, Jeffrey T Kuvin, Ayan R Patel, Natesa G Pandian, Theo E Meyer, Gerard P Aurigemma, Dennis A Tighe.   

Abstract

Transient stress cardiomyopathy (TSC) is a cause of reversible left ventricular (LV) dysfunction that is increasingly recognized. Reports to date have focused primarily on LV involvement, with little attention paid to associated right ventricular (RV) dysfunction. With other forms of LV dysfunction, RV involvement has been shown to confer an adverse prognosis. Prevalence, clinical characteristics, and short-term prognosis of RV dysfunction in TSC remain ill-defined. Presenting echocardiograms of 40 patients with TSC were reviewed. RV function was assessed by evaluating regional wall motion and calculating a wall motion score index (WMSI). RV dysfunction was defined as a WMSI >1.0. Clinical and demographic characteristics of patients with and without RV dysfunction were compared. RV dysfunction was identified in 27% of patients (11 of 40). RV WMSI was 1.20 +/- 0.30 for the entire cohort compared with 1.72 +/- 0.30 for those with RV dysfunction (p <0.05). In each case with RV dysfunction, regional wall motion abnormalities involved the apex and spared the base. Patients with RV dysfunction had higher B-type natriuretic peptide levels, higher pulmonary artery systolic pressures, and longer hospital stays. RV dimensions, clinical characteristics, electrocardiographic findings, other biomarkers, and in-hospital complications were similar. In conclusion, RV wall motion abnormalities, predominantly involving the apex and sparing the base, occur in slightly >1/4 of cases of TSC. Although associated with higher B-type natriuretic peptide levels, higher pulmonary artery systolic pressures, and longer hospital stays, RV dysfunction was not associated with significant differences in short-term cardiac morbidity or increased early mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19576334     DOI: 10.1016/j.amjcard.2009.02.049

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Reverse takotsubo cardiomyopathy: after an episode of serotonin syndrome.

Authors:  Nishaki Kiran Mehta; Gerard Aurigemma; Zahi Rafeq; Oscar Starobin
Journal:  Tex Heart Inst J       Date:  2011

2.  Echocardiography in stress cardiomyopathy and acute LVOT obstruction.

Authors:  Anand Chockalingam; Gong-Yuan Xie; Kevin C Dellsperger
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-02       Impact factor: 2.357

Review 3.  Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools.

Authors:  Francesco Santoro; Adriana Mallardi; Alessandra Leopizzi; Enrica Vitale; Thomas Stiermaier; Paolo Trambaiolo; Matteo Di Biase; Ingo Eitel; Natale Daniele Brunetti
Journal:  Heart Fail Rev       Date:  2022-01-18       Impact factor: 4.214

Review 4.  Role of echocardiography for takotsubo cardiomyopathy: clinical and prognostic implications.

Authors:  Masaki Izumo; Yoshihiro J Akashi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

5.  Right ventricular strain assessment by cardiovascular magnetic resonance myocardial feature tracking allows optimized risk stratification in Takotsubo syndrome.

Authors:  Thomas Stiermaier; Torben Lange; Amedeo Chiribiri; Christian Möller; Tobias Graf; Uwe Raaz; Adriana Villa; Johannes T Kowallick; Joachim Lotz; Gerd Hasenfuß; Holger Thiele; Andreas Schuster; Ingo Eitel
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

6.  Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE).

Authors:  Rodolfo Citro; Hiroyuki Okura; Jelena R Ghadri; Chisato Izumi; Patrick Meimoun; Masaki Izumo; Dana Dawson; Shuichiro Kaji; Ingo Eitel; Nobuyuki Kagiyama; Yukari Kobayashi; Christian Templin; Victoria Delgado; Satoshi Nakatani; Bogdan A Popescu
Journal:  J Echocardiogr       Date:  2020-09-04

Review 7.  Impact of right ventricular impairment on morbidity and mortality in takotsubo syndrome-a meta-analysis of observational trials.

Authors:  Suchith Shetty; Aaqib H Malik; Manju Bengaluru Jayanna; Wilbert S Aronow; Alexandros Briasoulis; Kan Liu
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

8.  Observational study on Takotsubo-like cardiomyopathy: clinical features, diagnosis, prognosis and follow-up.

Authors:  Luca Cacciotti; Ilaria Passaseo; Giuseppe Marazzi; Giovanni Camastra; Giuseppe Campolongo; Sergio Beni; Fabrizio Lupparelli; Gerardo Ansalone
Journal:  BMJ Open       Date:  2012-10-11       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.